NICE published draft guidance recommending roflumilast (Daxas, AstraZeneca) for chronic obstructive pulmonary disease (COPD). In 2012, NICE issued guidance that recommended roflumilast only if patients were taking it as part of a research study. New evidence since that guidance was published led to a positive recommendation for routine use. The company estimates that around 122,000…
Celebrating World COPD Day 2015
PRESS RELEASE – For Immediate Release Celebrating World COPD Day, the European Institute of Women’s Health highlights it’s not too late to improve respiratory health in Europe Since 2002, World Chronic Obstructive Pulmonary Disease (COPD) Day raises awareness and works to improve care of COPD through events and campaigns in over 50 countries on the…